5 Key Takeaways | Hot Topics in Biopharma | Kilpatrick Townsend & Stockton LLP
Kilpatrick Townsend recently held its semi-annual KTIPS (Kilpatrick Townsend Intellectual Property Seminar) in California. Firm attorneys led two days of interactive discussions with clients on the latest developments in intellectual property law and any impact on the legal and business landscapes, potential challenges and opportunities, possible legislative reforms, and more.
April Abele Isaacson and Yifan Mao’s session, “Hot Topics in Biopharma: From Enablement to Written Description, Section 101 See more +
Kilpatrick Townsend recently held its semi-annual KTIPS (Kilpatrick Townsend Intellectual Property Seminar) in California. Firm attorneys led two days of interactive discussions with clients on the latest developments in intellectual property law and any impact on the legal and business landscapes, potential challenges and opportunities, possible legislative reforms, and more.
April Abele Isaacson and Yifan Mao’s session, “Hot Topics in Biopharma: From Enablement to Written Description, Section 101 Challenges and The Patent Eligibility Restoration Act of 2023,” provided an in-depth analysis of recent decisions related to enablement, written description, and patentability affecting the life sciences and other industries. This session offered a comprehensive understanding of the current legal framework, challenges, and potential legislative reforms.
* The opinions expressed are those of the attorneys and do not necessarily reflect the views of the firm or its clients. This video is for general information purposes and is not intended to be and should not be taken as legal advice. See less –
